Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-12-08

Clinical Trial Update: Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH)

View source ↗

Summary

This entry describes the RESAPH registry study on sarcoidosis-associated pulmonary hypertension, with the study status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Cincinnati | Conditions: Sarcoidosis, Pulmonary Hypertension | Status: UNKNOWN